Back to Directory
Last Updated: 09/06/2026
Inoviv
London
Founded 2017
Multiplexed LC-MS proteomics for biomarker development and clinical trials
Inoviv is a bioanalytical contract research company providing multiplexed, quantitative LC-MS targeted proteomics services to pharmaceutical and biotech clients.
Its platform supports biomarker discovery, patient stratification, companion diagnostic development, and treatment efficacy monitoring across clinical and preclinical drug development programmes.
The company operates GLP/CLIA-certified laboratories in London and at Alderley Park, with therapeutic area expertise spanning neurodegenerative disease, oncology, fibrosis, and rare diseases.
Company Notes
Previously Known As
EM Scientific
Member of